Next Generation Nuclear Medicine

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/a1/cc/9a/a1cc9a9e-a4bc-39aa-92d3-3cf6d0ab2b14/mza_15551501372172170772.jpg/600x600bb.jpg

Cognitio

ARCS Australia

27 episodes

2 days ago

Welcome to Cognitio, the weekly podcast by ARCS Australia, your go-to source for insights into the evolving world of medtech, pharmaceuticals, and life sciences. Hosted by Dr Tim Boyle, CEO of ARCS, this podcast delivers bite-sized updates, expert discussions, and professional development insights to keep you informed and ahead of the curve. Each episode features hot topics, regulatory updates, sector trends, and practical career guidance, with guest appearances from industry leaders, ARCS members, and emerging innovators from BioBeacon. Whether you're a seasoned professional or just starting

Medicine

Health & Fitness

RSS

All content for Cognitio is the property of ARCS Australia and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Medicine

Health & Fitness

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/43238377/43238377-1741754321693-fbfa5331b1537.jpg

Next Generation Nuclear Medicine

Cognitio

43 minutes 57 seconds

2 weeks ago

Next Generation Nuclear Medicine

Next Generation Nuclear Medicine: Powering the Future of Precision Health

In this episode of ARCS Cognitio, ARCS Australia CEO Tim Boyle leads a compelling conversation on the rapidly evolving world of next-generation nuclear medicines — where physics meets biology to transform how we diagnose and treat disease.

Joined by a panel of industry leaders — Christian Behrenbruch (Telix Pharmaceuticals), David James (formerly Sirtex Medical and OncoSil), Rosanne Robinson (Clarity Pharmaceuticals, ex ANSTO, and Cylotek), and Brad Walsh (Glytherix) — the discussion explores the technologies, supply chain challenges, and investment opportunities shaping the future of this dynamic sector.

From emerging isotopes and theranostics to Australia’s unique position as a regional hub for radiopharmaceutical innovation, this episode offers deep insights into one of the most exciting frontiers in modern medicine.

Tune in to discover how collaboration, capability, and clinical excellence are driving the next era of nuclear medicine — and how Australia can lead the charge.

🎧 Listen now and join the conversation at arcs.com.au.